Sysmex Inostics is a world-class CLIA lab based in Baltimore, Maryland and Hamburg, Germany, specializing in blood-based biomarker analyses for the detection and monitoring of elusive diseases, particularly cancer. With their ultra-sensitive liquid biopsy and biomarker analysis technologies, they strive to provide personal and accurate treatment options, ensuring that diseases like cancer do not have the final say.
Through their partnership with QIAGEN, another renowned company, Sysmex Inostics is able to anticipate and understand the specific needs of their clients throughout the clinical trial process, accelerating global access to companion diagnostics. Their testing technologies are optimized for ultra-sensitivity, offering high specificity and efficiency, resulting in less invasive and time-consuming procedures with increased confidence in the accuracy of the results.
Generated from the website